Cannabis Sativa (CBDS) Stock Price, News & Analysis

Company Overview

Cannabis Sativa, Inc. (OTCMKTS: CBDS) is a U.S.-based company engaged in the development, production and distribution of hemp-derived cannabinoid products. Originally founded in the early 2000s, the company rebranded in 2018 to focus exclusively on non-intoxicating cannabinoid formulations. Headquartered in San Diego, California, Cannabis Sativa maintains extraction and processing facilities that adhere to current Good Manufacturing Practices (cGMP) standards, ensuring consistency and quality across its product lines.

The company’s core business activities center on proprietary extraction and purification technologies designed to isolate bioactive hemp compounds such as cannabidiol (CBD), cannabidiolic acid (CBDA) and select minor cannabinoids. Its product portfolio spans bulk cannabinoid isolates, custom-formulated tinctures and finished consumer goods for use in nutraceutical, cosmeceutical and pharmaceutical applications. Through in-house analytical laboratories, Cannabis Sativa oversees every stage of production, from raw material testing to the finished product, to meet strict safety and potency benchmarks.

Cannabis Sativa serves markets throughout North America, with distribution channels in key U.S. states where hemp and hemp-derived products are legal under federal and state regulations. The company has also pursued export opportunities in Europe and Asia, aligning with jurisdictions that permit cannabidiol products for wellness and personal care. By forging partnerships with licensed growers and research institutions, Cannabis Sativa seeks to expand its geographic footprint while navigating evolving regulatory frameworks.

The leadership team at Cannabis Sativa includes Chief Executive Officer Eddie Dowling, whose background in agricultural biotechnology drives the company’s innovation agenda, and Chief Scientific Officer Dr. Miriam Jackson, a pharmacologist with experience in natural product drug development. The board of directors comprises industry veterans in compliance, manufacturing and marketing, reflecting the company’s emphasis on regulatory adherence and scalable growth. Looking ahead, Cannabis Sativa plans to advance its product pipeline through targeted research collaborations and strategic licensing agreements.

Key Stats

• Today's Range: $0.03 to $0.04
• 50-Day Range: $0.02 to $0.03
• 52-Week Range: $0.00 to $0.17
• Volume: 2.20 million shs
• Average Volume: 1.07 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Cannabis Sativa Stock Analysis - MarketRank™

Cannabis Sativa scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cannabis Sativa.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cannabis Sativa is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cannabis Sativa is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cannabis Sativa has recently decreased by 70.31%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cannabis Sativa does not currently pay a dividend.

Dividend Growth

Cannabis Sativa does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cannabis Sativa has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cannabis Sativa has recently decreased by 70.31%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.3 / 5
• News Sentiment: N/A

News Sentiment

Cannabis Sativa has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cannabis Sativa insiders have not sold or bought any company stock.

Percentage Held by Insiders

27.46% of the stock of Cannabis Sativa is held by insiders. A high percentage of insider ownership can be a sign of company health.

CBDS Stock Analysis - Frequently Asked Questions

How have CBDS shares performed this year?

Cannabis Sativa's stock was trading at $0.0870 at the beginning of the year. Since then, CBDS stock has decreased by 60.4% and is now trading at $0.0344.

How do I buy shares of Cannabis Sativa?

Shares of CBDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cannabis Sativa own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cannabis Sativa investors own include Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Cara Therapeutics (CARA), 22nd Century Group (XXII) and Sangamo Therapeutics (SGMO).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:CBDS
• CIK: 1360442
• Web: www.cannabissativainc.com
• Phone: (702) 762-3123
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A